Citadel Advisors’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$297K Buy
17,500
+8,400
+92% +$180K ﹤0.01% 10490
2025
Q4
$234K Sell
9,100
-9,800
-52% -$225K ﹤0.01% 10701
2025
Q3
$407K Sell
18,900
-33,100
-64% -$752K ﹤0.01% 9626
2025
Q2
$1.14M Sell
52,000
-116,400
-69% -$2.55M ﹤0.01% 6783
2025
Q1
$3.76M Buy
168,400
+46,200
+38% +$995K ﹤0.01% 4360
2024
Q4
$2.11M Buy
122,200
+44,900
+58% +$697K ﹤0.01% 5506
2024
Q3
$1.3M Sell
77,300
-110,500
-59% -$2.65M ﹤0.01% 6336
2024
Q2
$5.37M Buy
187,800
+76,100
+68% +$2.29M ﹤0.01% 3628
2024
Q1
$4.26M Buy
111,700
+61,600
+123% +$2.33M ﹤0.01% 4193
2023
Q4
$1.86M Sell
50,100
-31,900
-39% -$1.07M ﹤0.01% 5487
2023
Q3
$2.79M Buy
82,000
+12,400
+18% +$468K ﹤0.01% 4606
2023
Q2
$2.74M Sell
69,600
-34,900
-33% -$1.26M ﹤0.01% 4621
2023
Q1
$3.36M Buy
104,500
+14,900
+17% +$492K ﹤0.01% 4462
2022
Q4
$2.79M Buy
89,600
+62,800
+234% +$2.27M ﹤0.01% 4870
2022
Q3
$993K Sell
26,800
-2,400
-8% -$89.9K ﹤0.01% 7011
2022
Q2
$848K Sell
29,200
-25,200
-46% -$902K ﹤0.01% 7413
2022
Q1
$2.8M Buy
54,400
+5,300
+11% +$227K ﹤0.01% 5357
2021
Q4
$2.47M Sell
49,100
-21,400
-30% -$1.2M ﹤0.01% 5756
2021
Q3
$3.95M Sell
70,500
-29,200
-29% -$1.61M ﹤0.01% 4774
2021
Q2
$5.88M Buy
99,700
+34,600
+53% +$1.94M ﹤0.01% 4097
2021
Q1
$2.9M Sell
65,100
-43,800
-40% -$2.05M ﹤0.01% 5527
2020
Q4
$4.62M Buy
108,900
+12,200
+13% +$397K ﹤0.01% 3830
2020
Q3
$2.85M Buy
96,700
+27,000
+39% +$744K ﹤0.01% 4073
2020
Q2
$1.8M Buy
69,700
+24,800
+55% +$569K ﹤0.01% 4769
2020
Q1
$951K Buy
+44,900
New +$1.23M ﹤0.01% 5422

Other funds holding PGNY

Citadel Advisors's PGNY Position: Q1 2026 in Review

Citadel Advisors sold out of Progyny (PGNY) in Q1 2026, closing a stake of 2,160,796 shares — an estimated $46.3M sold.

Citadel Advisors first reported a position in PGNY in Q4 2019 and held it in 25 quarters. The position peaked at $78M in Q3 2023. 291 funds tracked by Wall St. Rank hold PGNY as of Q1 2026.

  • Citadel Advisors reported no remaining Progyny position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 2,160,796 Progyny shares in Q1 2026, an estimated $46.3M.
  • Citadel Advisors first reported a position in Progyny in Q4 2019 and held it in 25 quarters.
  • Citadel Advisors's Progyny position peaked at $78M in Q3 2023.
  • 291 funds tracked by Wall St. Rank held Progyny as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.